Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Romas

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Transactions of the American Association of Genito-Urinary Surgeons|January 1, 1979
Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methodsN A Romas, R J Veenema, K C Hsu, et al.
The Journal of Urology|January 1, 1976
Carcinoembryonic antigen and bladder carcinomaG Ionescu, N A Romas, L Ionascu, et al.
Annals of the New York Academy of Sciences|January 1, 1982
Clinical comparison of immunological assays for determining prostatic acid phosphataseN A Romas, L M Shaw, K C Hsu, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1995
5 alpha-Androstan-3 alpha,17 beta-diol is a hormone: stimulation of cAMP accumulation in human and dog prostateA M Nakhla, V D Ding, M S Khan, et al.
Cancer|June 1, 1978
Carcinoma of the prostate: treatment with external radiotherapyL Harisiadis, R J Veenema, J J Senyszyn, et al.
Urology|August 11, 1998
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety StudyG L Andriole, H A Guess, J I Epstein, et al.
Urology|April 10, 1999
Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years. The North American Finasteride Study GroupP B Hudson, R Boake, J Trachtenberg, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Transactions of the American Association of Genito-Urinary Surgeons|January 1, 1979
Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methodsN A Romas, R J Veenema, K C Hsu, et al.
The Journal of Urology|January 1, 1976
Carcinoembryonic antigen and bladder carcinomaG Ionescu, N A Romas, L Ionascu, et al.
Annals of the New York Academy of Sciences|January 1, 1982
Clinical comparison of immunological assays for determining prostatic acid phosphataseN A Romas, L M Shaw, K C Hsu, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1995
5 alpha-Androstan-3 alpha,17 beta-diol is a hormone: stimulation of cAMP accumulation in human and dog prostateA M Nakhla, V D Ding, M S Khan, et al.
Cancer|June 1, 1978
Carcinoma of the prostate: treatment with external radiotherapyL Harisiadis, R J Veenema, J J Senyszyn, et al.
Urology|August 11, 1998
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety StudyG L Andriole, H A Guess, J I Epstein, et al.
Urology|April 10, 1999
Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years. The North American Finasteride Study GroupP B Hudson, R Boake, J Trachtenberg, et al.
Pageof 5